| |
| |
|
| Insider
Information: |
Carter Paul Rutherford |
| Relationship: |
Director |
| City: |
Uxbridge, Middlesex |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,305 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,978,174 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,305 |
|
|
| Total
Value |
$3,978,174 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Commercial Ops |
2016-08-01 |
62,305 |
2014-02-10 |
0 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2022-06-16 |
0 |
2018-05-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-04-01 |
4 |
AS |
$98.04 |
$98,044 |
D/D |
(1,000) |
45,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-04-01 |
4 |
OE |
$80.65 |
$80,650 |
D/D |
1,000 |
46,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-04-08 |
4 |
OE |
$80.65 |
$80,650 |
D/D |
1,000 |
46,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-04-08 |
4 |
AS |
$100.00 |
$100,000 |
D/D |
(1,000) |
45,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-01 |
4 |
AS |
$103.18 |
$206,365 |
D/D |
(2,000) |
45,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-01 |
4 |
OE |
$80.65 |
$161,300 |
D/D |
2,000 |
47,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-10 |
4 |
D |
$103.85 |
$291,507 |
D/D |
(2,807) |
47,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
50,439 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-15 |
4 |
AS |
$110.00 |
$660,020 |
D/D |
(6,000) |
47,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-05-15 |
4 |
OE |
$40.56 |
$406,687 |
D/D |
6,000 |
53,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-06-01 |
4 |
AS |
$113.09 |
$339,278 |
D/D |
(3,000) |
47,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-06-01 |
4 |
OE |
$26.99 |
$104,120 |
D/D |
3,000 |
50,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-06-18 |
4 |
OE |
$26.99 |
$269,900 |
D/D |
10,000 |
57,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-06-18 |
4 |
AS |
$120.00 |
$1,200,025 |
D/D |
(10,000) |
47,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-07-01 |
4 |
AS |
$118.24 |
$354,729 |
D/D |
(3,000) |
47,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-07-01 |
4 |
OE |
$26.99 |
$80,970 |
D/D |
3,000 |
50,632 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
50,132 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-07-31 |
4 |
D |
$117.86 |
$158,993 |
D/D |
(1,349) |
48,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-08-03 |
4 |
AS |
$118.64 |
$595,920 |
D/D |
(5,000) |
48,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-08-03 |
4 |
OE |
$26.99 |
$134,950 |
D/D |
5,000 |
53,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-10-01 |
4 |
AS |
$98.59 |
$197,180 |
D/D |
(2,000) |
48,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-10-01 |
4 |
OE |
$26.99 |
$78,677 |
D/D |
2,000 |
50,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-10-26 |
4 |
AS |
$110.06 |
$165,092 |
D/D |
(1,500) |
48,783 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-10-26 |
4 |
OE |
$26.99 |
$40,485 |
D/D |
1,500 |
50,283 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Commercial Ops |
• – – |
2015-11-02 |
4 |
AS |
$108.36 |
$216,712 |
D/D |
(2,000) |
48,783 |
0 |
- |
|
106 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
